Poland· PL-100348473

Telmisartan EGIS

A telmisartan product containing telmisartanum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.

ATC C09CA07

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about telmisartanumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan is registered in 17 of 19 countries.

Countries holding a registration under ATC C09CA07 (telmisartan), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search telmisartan products by name

Telmisartan · ATC C09CA07

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of telmisartan costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.14 in France to $0.71 in Switzerland — a ×5.0 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Telmisartan · price per daily dose (40 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.71
IT Italy$0.16
US United States$0.15 (acquisition cost)
FR France$0.14

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Telmisartanum
Manufacturer: InPharm Sp. z o.o.
Country: Poland (PL)
ATC code: C09CA07
ATC class: Telmisartan
Defined daily dose: 40 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 1

1 priced

gtin
05909991229801
28 szt.
PLN 23.09

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

334 interactions on record for telmisartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check telmisartan against other medicines How interaction checks work

Telmisartan · interactions on record

334 records

7 severe
121 moderate
1 minor
124 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium gluconateA12BA05severe
Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Telmisartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Actelsar, Telmicard
Belgium · Telmisartan Eg, Telmisartan Teva
Bulgaria · Telsart, Tезео
Cyprus · Telmisartan Jubilant
Czechia · Telmisartan Egis, Telmisartan Ratiopharm
Germany · Telmisartan 1 A Pharma, Telmisartan Abz
Denmark · Telmisartan Medical Valley, Telmisartan Stada
Estonia · Telmisartaan Amarox, Telmisartan Ratiopharm
Spain · Telmark, Telmisartán Almus
Finland · Telmark, Telmisartan Amarox
France · Telmisartan Amarox, Telmisartan Arrow
United Kingdom (Northern Ireland) · Telmisartan Accord Healthcare, Telmisartan Amarox
Hungary · Tanydon, Telmisartan Egis
Ireland · Mirpresoc, Telmisartan Accord Healthcare Ireland
Iceland · Kinzalmono, Micardis
Italy · Telmisartan Almus, Telmisartan Alter
Liechtenstein · Kinzalmono, Micardis
Lithuania · Telmisartan Ingen Pharma, Telmisartan Inteli
Luxembourg · Telmisartan Eg, Telmisartan Micro Labs
Latvia · Telmisartan Ratiopharm, Tezeo
Netherlands · Telmisartan 1a Pharma, Telmisartan Amarox
Norway · Kinzalmono, Micardis
Portugal · Diterpris, Mirpresoc
Romania · Tezeo
Sweden · Telmark, Telmisartan Amarox
Slovakia · Telmark, Telmisartan Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c48fb90c-93cc-4103-9162-5823e6dbd2c6
GET /v1/drugs/c48fb90c-93cc-4103-9162-5823e6dbd2c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "80 mg",
  "packaging": "05909991229801 ¦ Rp ¦ 109444\n28 tabl.",
  "substance": "Telmisartanum 80 mg",
  "common_name": "Telmisartanum",
  "pl_product_id": "100348473",
  "pozwolenie_nr": "437/15",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-07-15"
}

API reference MCP server Plans

See everything about telmisartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console